1835 related articles for article (PubMed ID: 30778739)
21. Performance of Relative Enhancement on Multiphasic MRI for the Differentiation of Clear Cell Renal Cell Carcinoma (RCC) From Papillary and Chromophobe RCC Subtypes and Oncocytoma.
Young JR; Coy H; Kim HJ; Douek M; Lo P; Pantuck AJ; Raman SS
AJR Am J Roentgenol; 2017 Apr; 208(4):812-819. PubMed ID: 28125273
[TBL] [Abstract][Full Text] [Related]
22. Multiphasic enhancement patterns of small renal masses (≤4 cm) on preoperative computed tomography: utility for distinguishing subtypes of renal cell carcinoma, angiomyolipoma, and oncocytoma.
Pierorazio PM; Hyams ES; Tsai S; Feng Z; Trock BJ; Mullins JK; Johnson PT; Fishman EK; Allaf ME
Urology; 2013 Jun; 81(6):1265-71. PubMed ID: 23601445
[TBL] [Abstract][Full Text] [Related]
23. Sarcomatoid Renal Cell Carcinoma and Collecting Duct Carcinoma: Discrimination From Common Renal Cell Carcinoma Subtypes and Benign RCC Mimics on Multiphasic MDCT.
Young JR; Young JA; Margolis DJA; Sauk S; Sayre J; Pantuck AJ; Raman SS
Acad Radiol; 2017 Oct; 24(10):1226-1232. PubMed ID: 28528853
[TBL] [Abstract][Full Text] [Related]
24. Segmental enhancement inversion at biphasic multidetector CT: characteristic finding of small renal oncocytoma.
Kim JI; Cho JY; Moon KC; Lee HJ; Kim SH
Radiology; 2009 Aug; 252(2):441-8. PubMed ID: 19508984
[TBL] [Abstract][Full Text] [Related]
25. CT-based machine learning model to predict the Fuhrman nuclear grade of clear cell renal cell carcinoma.
Lin F; Cui EM; Lei Y; Luo LP
Abdom Radiol (NY); 2019 Jul; 44(7):2528-2534. PubMed ID: 30919041
[TBL] [Abstract][Full Text] [Related]
26. Small (< 4 cm) Renal Mass: Differentiation of Oncocytoma From Renal Cell Carcinoma on Biphasic Contrast-Enhanced CT.
Sasaguri K; Takahashi N; Gomez-Cardona D; Leng S; Schmit GD; Carter RE; Leibovich BC; Kawashima A
AJR Am J Roentgenol; 2015 Nov; 205(5):999-1007. PubMed ID: 26496547
[TBL] [Abstract][Full Text] [Related]
27. Aorta-Lesion-Attenuation-Difference (ALAD) on contrast-enhanced CT: a potential imaging biomarker for differentiating malignant from benign oncocytic neoplasms.
Dhyani M; Grajo JR; Rodriguez D; Chen Z; Feldman A; Tambouret R; Gervais DA; Arellano RS; Hahn PF; Samir AE
Abdom Radiol (NY); 2017 Jun; 42(6):1734-1743. PubMed ID: 28197683
[TBL] [Abstract][Full Text] [Related]
28. A deep-learning based artificial intelligence (AI) approach for differentiation of clear cell renal cell carcinoma from oncocytoma on multi-phasic MRI.
Nikpanah M; Xu Z; Jin D; Farhadi F; Saboury B; Ball MW; Gautam R; Merino MJ; Wood BJ; Turkbey B; Jones EC; Linehan WM; Malayeri AA
Clin Imaging; 2021 Sep; 77():291-298. PubMed ID: 34171743
[TBL] [Abstract][Full Text] [Related]
29. Differentiation of clear cell and non-clear cell renal cell carcinomas by all-relevant radiomics features from multiphase CT: a VHL mutation perspective.
Li ZC; Zhai G; Zhang J; Wang Z; Liu G; Wu GY; Liang D; Zheng H
Eur Radiol; 2019 Aug; 29(8):3996-4007. PubMed ID: 30523454
[TBL] [Abstract][Full Text] [Related]
30. Angiomyolipoma with minimal fat and non-clear cell renal cell carcinoma: differentiation on MDCT using classification and regression tree analysis-based algorithm.
Woo S; Cho JY; Kim SH; Kim SY
Acta Radiol; 2014 Dec; 55(10):1258-69. PubMed ID: 24259298
[TBL] [Abstract][Full Text] [Related]
31. Differentiation of oncocytoma and renal cell carcinoma in small renal masses (<4 cm): the role of 4-phase computerized tomography.
Bird VG; Kanagarajah P; Morillo G; Caruso DJ; Ayyathurai R; Leveillee R; Jorda M
World J Urol; 2011 Dec; 29(6):787-92. PubMed ID: 20717829
[TBL] [Abstract][Full Text] [Related]
32. Development of a Multiparametric Renal CT Algorithm for Diagnosis of Clear Cell Renal Cell Carcinoma Among Small (≤ 4 cm) Solid Renal Masses.
Al Nasibi K; Pickovsky JS; Eldehimi F; Flood TA; Lavallee LT; Tsampalieros AK; Schieda N
AJR Am J Roentgenol; 2022 Nov; 219(5):814-823. PubMed ID: 35766532
[No Abstract] [Full Text] [Related]
33. Using Aorta-Lesion-Attenuation Difference on Preoperative Contrast-enhanced Computed Tomography Scan to Differentiate Between Malignant and Benign Renal Tumors.
Grajo JR; Terry RS; Ruoss J; Noennig BJ; Pavlinec JG; Bozorgmehri S; Crispen PL; Su LM
Urology; 2019 Mar; 125():123-130. PubMed ID: 30552939
[TBL] [Abstract][Full Text] [Related]
34. Usefulness of multidetector computed tomography to differentiate between renal cell carcinoma and oncocytoma. A model validation.
Paño B; Soler A; Goldman DA; Salvador R; Buñesch L; Sebastià C; Nicolau C
Br J Radiol; 2020 Nov; 93(1115):20200064. PubMed ID: 32706993
[TBL] [Abstract][Full Text] [Related]
35. Validation of aorta-lesion-attenuation difference on preoperative contrast-enhanced computed tomography scan to differentiate between malignant and benign oncocytic renal tumors.
Grajo JR; Batra NV; Bozorgmehri S; Magnelli LL; Pavlinec J; O'Malley P; Su LM; Crispen PL
Abdom Radiol (NY); 2021 Jul; 46(7):3269-3279. PubMed ID: 33665734
[TBL] [Abstract][Full Text] [Related]
36. Deep learning based classification of solid lipid-poor contrast enhancing renal masses using contrast enhanced CT.
Oberai A; Varghese B; Cen S; Angelini T; Hwang D; Gill I; Aron M; Lau C; Duddalwar V
Br J Radiol; 2020 Jul; 93(1111):20200002. PubMed ID: 32356484
[TBL] [Abstract][Full Text] [Related]
37. The value of quantitative CT texture analysis in differentiation of angiomyolipoma without visible fat from clear cell renal cell carcinoma on four-phase contrast-enhanced CT images.
You MW; Kim N; Choi HJ
Clin Radiol; 2019 Jul; 74(7):547-554. PubMed ID: 31010583
[TBL] [Abstract][Full Text] [Related]
38. External Validation of a Five-Tiered CT Algorithm for the Diagnosis of Clear Cell Renal Cell Carcinoma: A Retrospective Five-Reader Study.
Lemieux S; Shen L; Liang T; Lo E; Chu Y; Kamaya A; Tse JR
AJR Am J Roentgenol; 2023 Sep; 221(3):334-343. PubMed ID: 37162037
[No Abstract] [Full Text] [Related]
39. Predicting the ISUP grade of clear cell renal cell carcinoma with multiparametric MR and multiphase CT radiomics.
Cui E; Li Z; Ma C; Li Q; Lei Y; Lan Y; Yu J; Zhou Z; Li R; Long W; Lin F
Eur Radiol; 2020 May; 30(5):2912-2921. PubMed ID: 32002635
[TBL] [Abstract][Full Text] [Related]
40. Pretreatment differentiation of renal cell carcinoma subtypes by CT: the influence of different tumor enhancement measurement approaches.
Zokalj I; Marotti M; Kolarić B
Int Urol Nephrol; 2014 Jun; 46(6):1089-100. PubMed ID: 24381132
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
